- Presentations
- 3
- Markets
- 1
Omlyclo is a brand of Omalizumab marketed by Celltrion, with 3 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Omalizumab
- Brand owner
- Celltrion
- Registered in
- United States
- Strengths and forms
- 150 mg/1 mL injection, 300 mg/2 mL injection, 75 mg/0.5 mL injection
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Omlyclo 150 mg/1 mL injectionSubcutaneous Cold chain | Celltrion | US FDA | Available on request |
| Omlyclo 300 mg/2 mL injectionSubcutaneous Cold chain | Celltrion | US FDA | Available on request |
| Omlyclo 75 mg/0.5 mL injectionSubcutaneous Cold chain | Celltrion | US FDA | Available on request |
Equivalent brands
Other brands of Omalizumab.
Brand names and trademarks belong to their owners and are used only to identify products.
Request Omlyclo
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.